Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
McKinsey
UBS
Express Scripts
Cipla
Fuji
US Army
Moodys
Chubb

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,840,754

« Back to Dashboard

Summary for Patent: 5,840,754
Title: Dosage form comprising oxybutynin
Abstract:A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
Inventor(s): Guittard; George V. (Cupertino, CA), Jao; Francisco (San Jose, CA), Marks; Susan M. (San Jose, CA), Kidney; David J. (Palo Alto, CA), Gumucio; Fernando (Santa Clara, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:08/706,576
Patent Claim Types:
see list of patent claims
Use; Dosage form;

Drugs Protected by US Patent 5,840,754

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,840,754

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
France 2734483 ➤ Try a Free Trial
United Kingdom 9723081 ➤ Try a Free Trial
United Kingdom 2318055 ➤ Try a Free Trial
Canada 2510391 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Express Scripts
Citi
UBS
QuintilesIMS
US Army
Deloitte
Daiichi Sankyo
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.